Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Rapid Micro Biosystems, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

LEXINGTON, MASS., AUG. 12, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE30, 2025.

RAPID MICRO BIOSYSTEMS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

LEXINGTON, MASS., AUG. 12, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY OR RAPID MICRO), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THAT IT HAS ENTERED INTO A FIVE-YEAR, $45 MILLION TERM LOAN FACILITY WITH TRINITY CAPITAL INC. (NASDAQ: TRIN) (TRINITY CAPITAL).

RAPID MICRO BIOSYSTEMS ENTERS INTO FIVE-YEAR, $45 MILLION TERM LOAN FACILITY WITH TRINITY CAPITAL INC.

LEXINGTON, MASS., JULY 31, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION-CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, WILL RELEASE SECOND QUARTER 2025 FINANCIAL RESULTS PRIOR TO THE MARKET OPEN ON TUESDAY, AUGUST 12, 2025.

RAPID MICRO BIOSYSTEMS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 12, 2025

LEXINGTON, MASS., JUNE 13, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THE GRANTS ON JUNE 2, 2025, OF (I) 160,000 RESTRICTED STOCK UNITS (RSUS) OF THE COMPANY'S CLASS A COMMON STOCK (COMMON STOCK) AND (II) NON-QUALIFIED STOCK OPTIONS TO PURCHASE AN AGGREGATE OF 250,000 SHARES OF COMMON STOCK (THE OPTIONS) AS A MATERIAL INDUCEMENT TO EMPLOYMENT TO A NEW EMPLOYEE. ALL SUCH EQUITY AWARDS WERE MADE UNDER THE COMPANY'S INDUCEMENT PLAN, AS AMENDED (THE INDUCEMENT PLAN) AND WERE APPROVED BY A MAJORITY OF THE INDEPENDENT DIRECTORS OF THE BOARD OF DIRECTORS OR A DULY AUTHORIZED COMMITTEE THEREOF IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4). THE EQUITY AWARDS ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE INDUCEMENT PLAN, AND THE TERMS AND CONDITIONS OF THE APPLICABLE STOCK OPTION AND RSU AWARD AGREEMENTS COVERING THE GRANTS.

RAPID MICRO BIOSYSTEMS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

LEXINGTON, MASS., MAY 27, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY OR RAPID MICRO), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, IS PLEASED TO WELCOME DR. DAFNI BIKA TO THE COMPANY'S BOARD OF DIRECTORS (THE BOARD).

RAPID MICRO BIOSYSTEMS ANNOUNCES APPOINTMENT OF DR. DAFNI BIKA TO BOARD OF DIRECTORS

LEXINGTON, MASS., MAY 09, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH31, 2025.

RAPID MICRO BIOSYSTEMS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

LEXINGTON, MASS., APRIL 24, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION-CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, WILL RELEASE FIRST QUARTER 2025 FINANCIAL RESULTS PRIOR TO THE MARKET OPEN ON FRIDAY, MAY 9, 2025.

RAPID MICRO BIOSYSTEMS TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS ON MAY 9, 2025

LEXINGTON, MASS., MARCH 12, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THE GRANTS (I) ON MARCH 3, 2025, OF 50,000 RESTRICTED STOCK UNITS (RSUS) OF THE COMPANY'S CLASS A COMMON STOCK (COMMON STOCK) AS A MATERIAL INDUCEMENT TO EMPLOYMENT OF ONE NEW EMPLOYEE AND (II) ON MARCH 10, 2025, OF NON-QUALIFIED STOCK OPTIONS TO PURCHASE AN AGGREGATE OF 250,000 SHARES OF COMMON STOCK (THE OPTIONS) AND 174,000 RSUS AS A MATERIAL INDUCEMENT TO EMPLOYMENT TO TWO NEW EMPLOYEES. ALL SUCH EQUITY AWARDS WERE MADE UNDER THE COMPANY'S INDUCEMENT PLAN, AS AMENDED (THE INDUCEMENT PLAN) AND WERE APPROVED BY A MAJORITY OF THE INDEPENDENT DIRECTORS OF THE BOARD OF DIRECTORS OR A DULY AUTHORIZED COMMITTEE THEREOF IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4). THE EQUITY AWARDS ARE SUBJECT TO THE TERMS AND CONDITIONS OF THE INDUCEMENT PLAN, AND THE TERMS AND CONDITIONS OF THE APPLICABLE STOCK OPTION AND RSU AWARD AGREEMENTS COVERING THE GRANTS.

LEXINGTON, MASS., FEB. 28, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER31, 2024.

RAPID MICRO BIOSYSTEMS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES 2025 GUIDANCE

SIGNIFICANTLY EXTENDS COMMERCIAL REACH OF GROWTH DIRECT THROUGH EXPANDED GLOBAL SALES CHANNELS; ENABLES OPPORTUNITIES FOR COLLABORATION ON SUPPLY CHAIN EFFICIENCIES, SERVICES, AND JOINT PRODUCT DEVELOPMENT. SIGNIFICANTLY EXTENDS COMMERCIAL REACH OF GROWTH DIRECT THROUGH EXPANDED GLOBAL SALES CHANNELS; ENABLES OPPORTUNITIES FOR COLLABORATION ON SUPPLY CHAIN EFFICIENCIES, SERVICES, AND JOINT PRODUCT DEVELOPMENT.

RAPID MICRO BIOSYSTEMS ANNOUNCES GLOBAL DISTRIBUTION AND COLLABORATION AGREEMENT WITH THE LIFE SCIENCE BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY

LEXINGTON, MASS., FEB. 26, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, TODAY ANNOUNCED THAT THE COMPANY WILL PARTICIPATE IN THE FOLLOWING INVESTOR CONFERENCES.

RAPID MICRO BIOSYSTEMS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

LEXINGTON, MASS., FEB. 20, 2025 (GLOBE NEWSWIRE) -- RAPID MICRO BIOSYSTEMS, INC. (NASDAQ: RPID) (THE COMPANY), AN INNOVATIVE LIFE SCIENCES TECHNOLOGY COMPANY PROVIDING MISSION-CRITICAL AUTOMATION SOLUTIONS TO FACILITATE THE EFFICIENT MANUFACTURING AND FAST, SAFE RELEASE OF HEALTHCARE PRODUCTS, WILL RELEASE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS PRIOR TO THE MARKET OPEN ON FRIDAY, FEBRUARY 28, 2025.

Rapid Micro Biosystems, Inc.

RPID

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Rapid Micro Biosystems, Inc.

RPID.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

RPID